Daveen Chopra Edwards Lifesciences Corp (EW) insider trading activity

Daveen Chopra is CVP, TMTT of Edwards Lifesciences Corp. Currently has a direct ownership of 33,496 shares of EW, which is worth approximately $2.47 Million. The most recent transaction as insider was on May 22, 2025, when has been sold 1,500 shares (Common Stock) at a price of $75.08 per share, resulting in proceeds of $112,620. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.5K

21.44% 3M change

9.52% 12M change

Total Value Held $2.47 Million

Daveen Chopra Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 22 2025	SELL Open market or private sale	$112,620 $75.08 p/Share	1,500 Reduced 4.29%	33,496 Common Stock
May 11 2025	SELL Payment of exercise price or tax liability	$42,734 $73.68 p/Share	580 Reduced 1.63%	34,996 Common Stock
May 08 2025	BUY Grant, award, or other acquisition	-	9,200 Added 20.55%	35,576 Common Stock
May 07 2025	SELL Payment of exercise price or tax liability	$46,974 $74.92 p/Share	627 Reduced 2.32%	26,376 Common Stock
May 04 2025	SELL Payment of exercise price or tax liability	$21,862 $75.65 p/Share	289 Reduced 1.06%	27,003 Common Stock
May 03 2025	SELL Payment of exercise price or tax liability	$22,014 $75.65 p/Share	291 Reduced 1.05%	27,292 Common Stock
Dec 06 2024	SELL Open market or private sale	$128,222 $73.27 p/Share	1,750 Reduced 5.97%	27,583 Common Stock
Aug 20 2024	SELL Open market or private sale	$87,437 $69.95 p/Share	1,250 Reduced 4.09%	29,333 Common Stock
May 11 2024	SELL Payment of exercise price or tax liability	$71,197 $86.72 p/Share	821 Reduced 2.61%	30,583 Common Stock
May 07 2024	SELL Payment of exercise price or tax liability	$38,035 $85.09 p/Share	447 Reduced 1.4%	31,404 Common Stock
May 07 2024	BUY Grant, award, or other acquisition	-	7,000 Added 18.02%	31,851 Common Stock
May 04 2024	SELL Payment of exercise price or tax liability	$197,865 $85.25 p/Share	2,321 Reduced 8.54%	24,851 Common Stock
May 04 2024	BUY Exercise of conversion of derivative security	-	4,713 Added 14.78%	27,172 Common Stock
May 03 2024	SELL Payment of exercise price or tax liability	$24,752 $85.06 p/Share	291 Reduced 1.28%	22,459 Common Stock
Feb 21 2024	SELL Open market or private sale	$711,022 $86.71 p/Share	8,200 Reduced 26.49%	22,750 Common Stock
Feb 21 2024	BUY Exercise of conversion of derivative security	$414,820 $59.26 p/Share	7,000 Added 18.45%	30,950 Common Stock
Dec 15 2023	SELL Open market or private sale	$547,750 $78.25 p/Share	7,000 Reduced 22.62%	23,950 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	$414,820 $59.26 p/Share	7,000 Added 18.45%	30,950 Common Stock
Dec 06 2023	SELL Open market or private sale	$245,000 $70.0 p/Share	3,500 Reduced 12.75%	23,950 Common Stock
Dec 06 2023	BUY Exercise of conversion of derivative security	$207,410 $59.26 p/Share	3,500 Added 11.31%	27,450 Common Stock
Oct 03 2023	SELL Open market or private sale	$595,000 $70.0 p/Share	8,500 Reduced 26.19%	23,950 Common Stock
Oct 03 2023	BUY Exercise of conversion of derivative security	$503,710 $59.26 p/Share	8,500 Added 20.76%	32,450 Common Stock
Sep 06 2023	SELL Open market or private sale	$646,595 $76.07 p/Share	8,500 Reduced 26.19%	23,950 Common Stock
Sep 06 2023	BUY Exercise of conversion of derivative security	$503,710 $59.26 p/Share	8,500 Added 20.76%	32,450 Common Stock
Aug 29 2023	SELL Open market or private sale	$115,035 $76.69 p/Share	1,500 Reduced 5.89%	23,950 Common Stock

Daveen Chopra

CVP, TMTT

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account